Nothing Special   »   [go: up one dir, main page]

WO2001011961A1 - Control of ectoparasites using spinosyns - Google Patents

Control of ectoparasites using spinosyns Download PDF

Info

Publication number
WO2001011961A1
WO2001011961A1 PCT/US2000/017869 US0017869W WO0111961A1 WO 2001011961 A1 WO2001011961 A1 WO 2001011961A1 US 0017869 W US0017869 W US 0017869W WO 0111961 A1 WO0111961 A1 WO 0111961A1
Authority
WO
WIPO (PCT)
Prior art keywords
formulation
sheep
ppm
spinosyn
wool
Prior art date
Application number
PCT/US2000/017869
Other languages
French (fr)
Inventor
Kristina Clare Hacket
Lionel Barry Lowe
James Terence Rothwell
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Priority to AU66053/00A priority Critical patent/AU6605300A/en
Publication of WO2001011961A1 publication Critical patent/WO2001011961A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/22Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members

Definitions

  • This invention relates to A83543 compounds including analogues and
  • insects have been caused, and continues to be caused, by pests such as insects. Insects particularly
  • insects Approximately 1% of insects
  • insects are considered to be the carriers of more than 250 viruses
  • insecticide compositions It is estimated that there are at least 35,000 formulated
  • insecticide products worldwide with chemicals as the active ingredients.
  • Such insecticide products include antimicrobials, larvicides, insecticides, animal dips,
  • Plant-derived insecticides such as nicotine, rotenone, veratrine and
  • pyrethrum have also been used as natural contact insecticides to kill insect pests.
  • organophosphates are potentially toxic to sheep, goats, other small ruminants
  • organophosphate synthetic pyrethroid or insect growth regulator insecticides
  • Aqueous wool scouring produces high volumes of effluent containing
  • insecticide residues can kill
  • That wool in a greasy form. That wool may be scoured and processed in many
  • Tissue residues are also a major concern when considering use of
  • insecticides are not without their problems, such as the difficulty in applying them, as
  • Chemosterilants which sterilise large segments of insect pest
  • Fermentation product A83543, also known as spinosyn includes a
  • spinosyns produced by Saccharopolyspora spinosa.
  • spinosyns B Compared to spinosyn A, spinosyns B
  • strains of S.spinosa produce a mixture of spinosyns, the primary components of
  • spinosyn A 50-85%
  • spinosyn D 15-50%)
  • spinosad refers to a mixture of spinosyn A and spinosyn D.
  • the present invention provides an insecticidal formulation for
  • the formulation may additionally
  • the amount of the spinosyn comprises another insecticidal agent.
  • the amount of the spinosyn comprises another insecticidal agent.
  • present in the formulation is such that the spinosyn residue in any wool, milk or tissue
  • the amount of spinosyn in the formulation is selected from the formulation.
  • the amount of spinosyn in the formulation is selected from the formulation.
  • a preferred amount is 25 g/L.
  • this invention relates to an article of manufacture
  • a topical unit dose of a formulation of this invention i.e. one comprising an
  • This invention further relates to a use of a formulation of this
  • this invention provides the use of a formulation of
  • this invention i.e. one comprising an elective amount of a spinosyn, or an analogue
  • ectoparasite infestation in a small ruminant animal selected from a sheep, goat, or
  • camellid comprising topically administering the formulation to the animal.
  • This invention further provides a method of controlling an ectoparasite
  • a formulation of the invention i.e., one comprising an
  • the amount of spinosyn in the formulation is such that the spinosyn residue in any
  • the present invention provides formulations and methods of
  • insects and arachnids in small ruminant animals such as sheep, goats and camellids
  • A83543 compounds by applying one or more A83543 compounds in an acceptable carrier or diluent.
  • Another aspect of this invention is a method for preventing, controlling
  • insects including ectoparasites in small ruminant animals by
  • insecticide including one or more
  • the invention also provides a method for controlling an ectoparasitic
  • the ectoparasite includes lice, fleas, ked, mites, itch mites, ticks
  • spinosyn or an analogue or derivative thereof, at a concentration of about 50 ppm or
  • concentration of about 50 ppm of spinosyn is achieved by administering an amount of
  • the invention further provides a method for controlling an
  • ectoparasitic infestation wherein the ectoparasite includes lice, ked and blowfly
  • sheep are about 10, 3, and 1 ppm of spinosyn in the formulation.
  • the invention provides a method for controlling an
  • the spinosyn in the sheep is present in an environmentally acceptable amount
  • sheep are about 25, 20, or 10 ppm.
  • Still another aspect of this invention provides a method for controlling
  • Another aspect of this invention provides a method for controlling an
  • an analogue or derivative thereof at a concentration of about 50 ppm or less , such
  • 'insect' is defined to include, but is not
  • Phthiraptera and Acarina, and parasites and other insects which are parasitic during
  • 'small ruminant' or 'small ruminant animal' refers to sheep
  • goats or camellids including alpacas, llamas and vacuna, etc.
  • A83543 compound is also used herein to mean an
  • controlling an insect infestation refers to preventing onset
  • 'effective amount means the amount which is sufficient to
  • the term 'short wool sheep' means sheep with 6 weeks or less growth
  • 'withholding period means the period after treatment during
  • the withholding period of course differs in respect of the chemical nature of the
  • Meat (mammalian in the fat) has an
  • allowable amounts depend on the aquatic toxicity profile of the chemical.
  • concentration of spinosad is estimated to be approximately 15 mg/kg or higher.
  • This invention is based on the surprising discovery in sheep that the
  • spinosyns i.e. a spinosyn factor or an analogue and derivative thereof, exhibit
  • insecticidal activity at very low concentrations, much lower than those used or
  • spinosyn compounds have 100% efficacy as insecticides, particularly ectoparasiticides.
  • Spinosyn compounds are usually in the form of either an emulsion
  • formulations can be supplied as dilute ready-to-use
  • invention is of utility against parasite populations on sheep or small ruminants that
  • formulations of the present invention can be any formulations of the present invention having existing levels of resistance to currently used products.
  • the formulations of the present invention can be any formulation of the present invention having existing levels of resistance to currently used products.
  • the formulations of the present invention can be any formulation of the present invention having existing levels of resistance to currently used products.
  • camellids including alpacas, llamas and vacuna etc.
  • Such pests include
  • ectoparasites such as blowfly strike, lice, ked, mites, itch mite, sheep scab, screw
  • the spinosyns can be
  • Formulations containing the spinosyns are generally administered
  • Topical application can take the form of
  • Topical insecticidal formulations include spot-ons, pour ons, sprays,
  • suspensions are preferred. More preferred are dip wash formulations, jetting fluid
  • the active component-the spinosyn factor/compound- may be present
  • A83543A and A83543D or a mixture of at least one A83543 compound
  • One preferred active component used in the method of the present invention is
  • spinosad which is a product comprised of 50-85% spinosyn A and 50-15% spinosyn
  • the active component-the spinosyn factor/compound- may also be any active component-the spinosyn factor/compound-.
  • spinosyn A can be any organic compound having the same side chain prepared using standard procedures for salt preparation.
  • spinosyn A can be any organic compound having the same side chain prepared using standard procedures for salt preparation.
  • spinosyn A can be any organic compound having the same side chain prepared using standard procedures for salt preparation.
  • salts formed by reaction with either an organic or inorganic acid such as, for example
  • the spinosyn factor/s or analogues or derivatives thereof can be mixed
  • compositions of the present invention can take the form of
  • the formulations of the active spinosyn compound are in
  • emulsifiable formulations are generally liquids, generally called emulsifiable
  • the active formulations are in the form
  • Emulsifiable concentrates and solution concentrates as
  • a preferred concentration range is 1-500 g/L of
  • concentration range is selected from the
  • Useful organic solvents include aromatics
  • terpenic solvents including rosin derivatives, aliphatic ketones such as
  • SC Suspension concentrates
  • water-insoluble compound including one or more spinosyn compounds
  • an aqueous vehicle at a concentration in the range of from about 1-500 g/L.
  • concentration range is selected from the group consisting of about 1-
  • suspensions are prepared by finely grinding
  • surfactants chosen from such types as nonionic, sulfonated lignins and alkylsulfates
  • suspending agents such as xanthan and guar gums.
  • Other inert ingredients may be used.
  • the suspension concentrates and emulsions are preferably diluted with
  • the active A83543 compounds can also be any active A83543 compounds applied in the methods of the invention.
  • the active A83543 compounds can also be any active A83543 compounds.
  • composition In such compositions, the active spinosyn compound is dissolved in an
  • inert carrier which is a propellant mixture.
  • formulations of the invention include dust carriers, solvents, emulsif ⁇ ers, wetting and
  • the insecticide takes the form of an
  • Wettable powders can be used as spray
  • carrier such as an absorbtive clay
  • the method of the invention can be applied as an early
  • the active spinosyn compound or compounds are any active spinosyn compound or compounds.
  • ppm 25 ppm, 20 ppm, 10 ppm, 5 ppm, 4 ppm, 3 ppm, 2 ppm, or 1 ppm.
  • a preferred composition for use in the present methods of treatment is
  • a dispersant may be added to improve suspendability.
  • a preferred formulation contains the following ingredients: Ingredient Percent (w/w) Sample batch (2)
  • the spinosyn is wet-
  • grind batch i.e., spinosad, surfactant, water, and antifoam as needed.
  • a "hydrated suspension batch” is also formed by blending a hydrated
  • a typical hydrated suspension batch contains the
  • a particularly useful mineral thickener is colloidal magnesium
  • aluminum silicate such as VEEGUM, that disperses and wells in water.
  • xanthan gum in one that is heat stable with a good tolerance for strongly acidic and
  • emulsifiable concentrates containing spinosad can be made and used for
  • emulsifiable concentrate can be prepared in an aromatic hydrocadrbon such as
  • Aromatic 150 containing the following ingredients: spinosad (90% active ingredient,
  • treating ectoparasites in sheep can be performed in the following manner:
  • sheep should be hand jetted with about 25 ppm spinosad; 0.5 L should be used per
  • Example 1 Spinosad Dip Formulations for the Control of Bovicola Ovis on Sheep
  • Subsections (a) - (g) provide the lice counts observed with the control animals and
  • Example 2a Dose determination for the treatment of sheep body lice
  • emulsifiable concentrate was diluted 1 :1000 in water to obtain formulations of 0, 1.0,
  • suspension concentrate (25 g/L) was diluted in water to give 0, 2, 5, 15 and 45 ppm
  • control sheep i.e., those treated with 0 ppm
  • Example 2b Evaluation of spinosad for the treatment of blowfly strike on sheep caused by Lucilia cuprina
  • spinosad were diluted 1 : 1000 in water to give emulsions of 2, 5, 15, 45 and 135 ppm.
  • maggots Each site was examined for maggot survival and development 24, 48 and 72
  • Example 2c Evaluation of spinosad for the treatment of sheep ked (M. ovinus)
  • Example 3a Dose confirmation and protection period for the treatment of sheep body lice (Bovicola ovis) i) Short wool sheep, application ⁇ six (6) weeks after shearing in the form of a dip
  • ppm spinosad were sampled on days 1, 2, 4, 7, 9, 11, 14, 17 and 21 post treatment
  • Example 5 Spinosad residues in sheep meat, fat and offal four days following dipping in 50 ppm spinosad dip formulation
  • Two previously sheared sheep were dipped in an aqueous suspension dip formulation containing 50 ppm spinosad for 30 seconds, with the head being dunked twice, and then placed in a floor pen for four days.
  • the sheep were sacrificed and necropsied at the end of those four days; and samples of kidney, liver, muscle, perirenal and abdominal fat were collected.
  • the tissues were transferred to a -20°C freezer until processing.
  • the tissue samples were chopped, frozen with dry ice and then ground using a hammermill. The samples were then placed in a -20°C freezer until assay.
  • Example 6 Measurement of the residue decay profile of spinosad in sheep wool following dipping in 10 ppm spinosad and jetting with 25 ppm spinosad.
  • the wool in a processing lot is made up of wools treated in early season, wools treated in late season, untreated wools, and wools treated with other chemicals. This blending will allow the spinosad residue from any farm to be diluted by these other wools. Therefore treatment of sheep with spinosad at the recommended rates will not cause wool residues to breach any wool scour environmental parameters and will not require the establishment of a wool with-holding period following treatment.
  • Spinosad has a high margin of safety for farm workers due to the short half-life of spinosad in wool grease, the very low level of dermal absorption and low mammalian toxicity of the active ingredient. Sheep treated with spinosad present no risk to shearers, wool handlers or other farm workers.
  • Example 7 Tissue residues following dipping in 10 ppm spinosad and jetting with 25 ppm spinosad. Thirty seven fine wool Merino ewes and wethers with 6 weeks wool
  • the limit of quantification (LOQ) was 0.01 mg/kg and the limit of detection (LOD)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides formulations for controlling insects/pests in small ruminants, such as camellids, sheep, and goats, the formulations comprising an effective amount of a spinosyn, or an analogue or derivative thereof, together with an acceptable carrier or diluent, and methods of controlling these insect pests comprising topically applying these formulations to a ruminant.

Description

CONTROL OF ECTOPARASITES USING SPINOSYNS
This invention relates to A83543 compounds including analogues and
derivatives thereof, and in particular the application of such compounds as
insecticides in controlling lice, flies and other ectoparasites and related arthropod
pests which infest sheep, goats, other small ruminant species and camelids (including
alpacas, llamas, vacuna). Historically, the greatest damage to domestic animals has
been caused, and continues to be caused, by pests such as insects. Insects particularly
represent a cause for concern as they are the most numerous of all living organisms
and constitute approximately 72% of all animal species. Approximately 1% of insects
are considered pests in that they attack humans and/or domestic animals, transmit
human, animal and plant diseases, destroy objects and structures and compete for food
and other necessities.
The losses resulting from insect-caused human and animal diseases are
enormous. In fact, insects are considered to be the carriers of more than 250 viruses
which are pathogens of humans and higher animals. The numbers of human deaths
caused by mosquito-transmitted diseases such as malaria and lymphatic filariasis are
huge. Flies also transmit human- and animal-related diseases such as trachoma,
trypanosomiasis and river blindness. Other human and animal diseases are
transmitted by fleas and lice.
To date, the primary method for controlling insects, particularly in respect of
domestic animals and crops, has been by the application of synthetic chemical
insecticide compositions. It is estimated that there are at least 35,000 formulated
insecticide products worldwide with chemicals as the active ingredients. Such insecticide products include antimicrobials, larvicides, insecticides, animal dips,
avicides and disinfectants.
The extensive use of chemical insecticides since the 1940s has resulted
in a large number of problems, including widespread insect resistance, emergence of
secondary pests, hazards to human and animal health, as well as detrimental effects on
fish and birds and environmental pollution.
Many insect species have developed resistance to the action of specific
insecticides so as to necessitate changes in control practices. There is an ever
widening pool of insect pests which are developing multiple resistance. The resistant
genes persist in insect genomes, precluding successful reuse of an insecticide to
control an insect population with resistant genes. Thus, there are increasing reasons to
develop new insecticides due to insect resistance.
Plant-derived insecticides such as nicotine, rotenone, veratrine and
pyrethrum have also been used as natural contact insecticides to kill insect pests.
However, the disadvantage with some plant-derived insecticides is their toxicity to
humans, animals and fish.
Insecticide residues are also seen as a major problems resulting from
chemical usage. With the exception of microbial insecticides, nearly all insecticides
result in residues of various chemicals and their degradation products or metabolites
which may be present in detectable amounts (ppb to ppm) in food despite food
processing. With increasing use of insecticides, the nature and magnitude of such
persisting residues have assumed great significance in public health. Potential
environmental risks include threats to ground water or surface water (lakes, dams,
rivers, streams). The persistence, mobility and potential for accumulation of an insecticide and its primary degradates must be considered in order to assess the
environmental impact of the use of an insecticide. Concern about the fate of bio-
active chemicals introduced into the environment has led to strict regulations on
release of insecticide waste into water, as well as for proper disposal of containers and
waste from use of insecticides. Other factors such as corrosiveness, explosiveness
and flammability of the insecticide must also be considered.
Some of the currently used products, such as pyrethroids and
organophosphates (OP's), are potentially toxic to sheep, goats, other small ruminants
and camelids, to the human operator who applies the treatment, and to the
environment, such as when run-off or the effluent from wool processing plants is
discharged into water ways. Thus, a potentially broad spectrum of toxicities exists
with respect to insecticides used in the treatment or eradication of ectoparasites.
It is acknowledged that the use of insecticides is essential for high
yield production of quality wool and to protect sheep from attack by ectoparasites
(mainly lice and blowfly) through the growing season. Inevitably, however, the use
of insecticides leaves some residue in the wool at shearing time. Accordingly, wool
residues resulting from currently used '.. isecticides are of major concern. Particularly,
use of insecticides in late season treatments can lead to the occurrence of residues in
the fleece at shearing. Late season backline and jetting treatments have been studied
to calculate the dissipation of the active agents and to assess the spread of insecticide
through the fleece. Insecticide formulations using representative members of
organophosphate, synthetic pyrethroid or insect growth regulator insecticides
commonly used to control lice and flies on sheep often leave high levels of wool
residues when applied as late season backline treatments or as late season jetting applications. The residues resulting from such standard, currently used products have
been the cause of concern in the wool industry for some time. Further, the use of
these products can also result in environmental discharge limits being exceeded.
The two processing issues with the highest priority relate to 1) the
acceptability of lanolin products that are made from wool wax that is recovered during
scouring, and 2) the residues that associate with the wool wax that is discharged from
the scour with the processing wastes. Insecticides in the wool wax that is recovered
when the wool is scoured may partially survive the lanolin refining process unless
special steps are taken. For example, several years ago, diazinon was found in some
samples of pharmaceutical lanolin and was considered a potential health hazard to
infants.
Aqueous wool scouring produces high volumes of effluent containing
emulsified wool wax, dirt and insecticides. While this effluent is treated before
discharge to the environment, the impact on the environment depends on the extent of
effluent treatment and dilution after scouring and on the location of the scour. If
present in high enough concentrations in the effluent, insecticide residues can kill
beneficial aquatic fauna which help the process of sewage degradation. Once released
from sewage systems into streams or rivers, these chemical residues can interfere with
the waterway food chain.
Currently, Australia and other countries export a substantial amount of
their wool in a greasy form. That wool may be scoured and processed in many
different countries and environmental locations, leaving international environmental
issues as a major concern when considering wool residues. European environmental
authorities have commenced the introduction of tough new guidelines for discharge of chemicals into waterways. These regulations mean that both wool processors and
growers have to change their practices if European customers are to continue to
process wool. The total concentration of organophosphates and synthetic pyrethroids
in the Australian wool clip in 1994-1995 averaged 10 mg/kg (ppm) on greasy wool.
While this amount has been reduced over the last two years, Europe has indicated that
chemical residue levels on greasy wool will need to be reduced to 1-2 mg/kg over the
next 9 years in order to comply with new EC standards. For some pesticides, residue
levels must be even lower.
It is to be noted that the Australian wool industry has set a goal to
reduce the level of insecticide residues in the wool clip over the next few years, and
therefore new safer insecticides are required. Other wool growing countries in the
International wool network are also moving to reduce residues of all insecticides.
Europe, Canada, Japan and New Zealand all have eco-labelling schemes of wool and
textile products which focus on absence of toxic substances, etc. In order to
accomplish these goals, new, safer, low residue insecticides will be required.
Tissue residues are also a major concern when considering use of
insecticides on domestic animals. App!.' cation of an insecticide to a domestic animal
may result in toxic chemical residues being collected in the meat/tissue of the animal.
Human consumption of meat or other products from domestic animals can result in
human ingestion of such insecticidal residues.
Accordingly, insect and pest control has been sought to be directed
away from exclusive reliance on insecticides and towards the optimisation of
environmental and economic insect and pest control (integrated pest management).
The application of microbial control in which insects are attacked by pathogens such as viruses, bacteria, fungi and protozoa are favoured as such microbial insecticides are
highly selective for insect pests and do not leave toxic residues. However, microbial
insecticides are not without their problems, such as the difficulty in applying them, as
well as confining the natural enemy/parasite/disease to a large area. Further, they also
have the disadvantages of short residual action and extreme specificity, which limit
general applicability.
Genetic engineering has most recently been applied in the area of
insecticides through the release of sterilised male insects and mass introduction of
deleterious mutations such as chromosomal translocations. However, such procedures
are very expensive, and stringent criteria are required before release of sterile males is
contemplated. Chemosterilants which sterilise large segments of insect pest
populations are also known, but these are strong carcinogens which precludes their
use.
The search for new substances or approaches to pests and insect
control has assumed increasing significance in public health in view of the use of
chemical insecticides (and their environmental and economic viability), the nature and
magnitude of the persisting residues, a; J increased insect and pest resistance, together
with the toxicity levels of many synthetic chemical as well as natural chemical
insecticides.
Of particular concern in the wool industry are the products used by
woolgrowers to control or prevent lice and fly infestations. Currently, such products
include synthetic pyrethroids, insect growth regulators and organophosphate products
which cover nearly all the registered external parasitic treatments on small ruminants
such as sheep and goats. All lice and fly products start to break down from the date of application, but some of the chemicals remain in the fleece and tissue, as discussed
above. This residual amount depends on the chemical used and the timing and rate of
applications prior to shearing.
One specific problem in the wool industry is the late treatment of
flystrike and lice in sheep before shearing. Sheep treated for flystrike and lice in long
wool are a major source of high chemical residues on wool. To date, while the
industry has sought measures such as introducing the lice and flystrike treatment early
in the season and before 6 months before shearing, these measures are not often
effective. Consequently, the search for a lice and flystrike prevention treatment which
can be administered in the last 6 months of the growing season and which will
produce wool with low chemical residues while still controlling lice and flystrike is a
major commercial objective in the wool industry.
There is, therefore, a need for compounds which can be used as one or
more active principles in insecticides, particularly in respect of insects including
ectoparasites which afflict small ruminant economic animals, especially sheep and
goats, and which are effective at low application rates, selective in biologic action and
have low toxicity and a high margin of afety to humans, economic animals, aquatic
organisms and birds. Such compounds should also be ones from which no persisting
wool, tissue or other residues result, as well as being substances for which no insect or
pest resistance exists. The substances must be environmentally friendly in that there
must be demonstrably low impacts on the environment. They must also be
economically viable to use on a large scale, particularly in respect of late season
applications, that is applied within the last six months of the growing season. Fermentation product A83543, also known as spinosyn, includes a
family of related compounds (spinosyns) produced by Saccharopolyspora spinosa.
These are naturally derived fermentation products with a positive safety profile in
contrast to currently used synthetic organically derived compounds (such as synthetic
pyrethroids, organophosphates, organochlorines and carbamates), and have previously
been shown to exhibit insecticidal activity against insects affecting crops and transient
activity against larval blow fly and adult stable fly when administered systemically to
guinea pigs and sheep. By the terms "A83543 compounds" and "spinosyn and
derivatives and analogues thereof is meant components consisting of a 5,6,5-tricyclic
ring system, fused to a 12-membered macrocyclic lactone, a neutral sugar [2N,3N,4N-
(tri-O-methyl)rhamnose] and an amino sugar (forosamine), as described in the patents
discussed infra.
The family of compounds from A83543 fermentation product has been
shown to comprise individual compounds A83543A, A83453B, A83543C, A83453D,
A83543E, A83453F, A83543G, A83453H, A83543 J, A83453L, A83543M,
A83453N, A83543Q, A83453R, A83543S, A83453T, A83453U, A83543V,
A83453W, A83453X. Boeck et al. described spinosyns A-H and J and salts thereof
in US patent Nos 5,362,634, 5,496,932 and 5,571,901. Mynderse et al. described
spinosyns L-N, their N-demethyl derivatives and salts thereof in US patent No,
5,202,242. Turner et al. described spinosyns Q-T, their N-demethyl derivatives and
salts thereof in US patent Nos 5,591,606, 5,631,155 and 5,767,253. Spinosyns
K,O,P,U,V,W, and Y are described in the article by DeAmicis, CN. et al. in
American Chemical Society's Symposium Series: Phytochemicals for Pest Control (1997), Chapter 11 "Physical and Biological Properties of Spinosyns: Novel
Macrolide Pest-Control Agents from Fermentation," pp 146-154.
Spinosyn A (A83543A) was the first spinosyn isolated and identified
from the fermentation broth of Saccharapolyspora spinosa. Subsequent examination
of the fermentation broth revealed that the parent strain oϊ S. spinosa produced a
number of spinosyns (A83543A to H and J). Compared to spinosyn A, spinosyns B
to H and J are characterised by differences in the substitution patterns on the amino
group of the forosamine, at selected sites on the ring system and on the neutral sugar.
The strains of S.spinosa produce a mixture of spinosyns, the primary components of
which are spinosyn A (50-85%) and spinosyn D (15-50%). These are the two
spinosyns that are currently known to be the most active as insecticides. The name
"spinosad" refers to a mixture of spinosyn A and spinosyn D.
The present invention provides an insecticidal formulation for
controlling an insect infestation in a small ruminant animal, said formulation
comprising an effective amount of a spinosyn, or an analogue or derivative thereof,
together with an acceptable carrier or diluent. The formulation may additionally
comprise another insecticidal agent. In me embodiment, the amount of the spinosyn
present in the formulation is such that the spinosyn residue in any wool, milk or tissue
obtained from the animal immediately, or within about a month, following application
of the formulation is at an environmentally acceptable level or safe to humans.
In these formulations, an effective amount of the spinosyn is present
when the amount of spinosyn in the formulation is from 1-500 g of the spinosyn /L of
the formulation. Preferably, the amount of spinosyn in the formulation is selected
from the group consisting of 1-500, 1-400, 1-350 , 1-300, 1-250, 1-200, 1-150, 1-100, 1-90, 1-80, 1-70, 1-60, 1-50, 1-40, 1-30, , 1-25 or 1-20 g of spinosyn per L of the
formulation. A preferred amount is 25 g/L.
In another aspect, this invention relates to an article of manufacture,
comprising packaging material and a formulation for controlling an insect infestation
in a small ruminant animal contained within said packaging material, wherein said
formulation comprises
a topical unit dose of a formulation of this invention, i.e. one comprising an
effective amount of a spinosyn, or an analogue or derivative thereof, together with an
acceptable carrier or diluent; and
wherein said packaging material comprises a label or package insert with instructions
for topically administering the dose to the animal.
This invention further relates to a use of a formulation of this
invention, i.e. one comprising an effective amount of a spinosyn, or an analogue or
derivative thereof, together with an acceptable carrier or diluent, in the preparation of
a medicament for controlling an insect infestation in a small ruminant animal.
In another aspect, this invention provides the use of a formulation of
this invention, i.e. one comprising an elective amount of a spinosyn, or an analogue
or derivative thereof, together with an acceptable carrier or diluent, for controlling an
ectoparasite infestation in a small ruminant animal selected from a sheep, goat, or
camellid, comprising topically administering the formulation to the animal.
This invention further provides a method of controlling an ectoparasite
infestation in a small ruminant selected from a sheep, goat or camellid, comprising
topically administering a formulation of the invention, i.e., one comprising an
effective amount of a spinosyn or an analogue or derivative thereof, to the ruminant. When carrying out this method, it is preferable to administer a formulation wherein
the amount of spinosyn in the formulation is such that the spinosyn residue in any
wool, milk or tissue obtained from the animal immediately, or within about a month,
following administration of the formulation is at an environmentally acceptable level.
Thus, the present invention provides formulations and methods of
controlling, i.e. preventing, ameliorating or eliminating, ectoparasites, including
insects and arachnids, in small ruminant animals such as sheep, goats and camellids
by applying one or more A83543 compounds in an acceptable carrier or diluent.
Another aspect of this invention is a method for preventing, controlling
and/or eliminating insects including ectoparasites in small ruminant animals by
administering an insecticide to the animal, said insecticide including one or more
spinosyn factors or analogues or derivatives thereof present
The invention also provides a method for controlling an ectoparasitic
infestation, wherein the ectoparasite includes lice, fleas, ked, mites, itch mites, ticks
and blowfly strike, in a small ruminant animal by administering to the animal, a
spinosyn, or an analogue or derivative thereof, at a concentration of about 50 ppm or
less, such that any wool, milk or tissue ■ .jsidue from the spinosyn in the animal is
present in an environmentally acceptable amount immediately or within about a
month following administration. In sheep, for example, an equivalent effect to a
concentration of about 50 ppm of spinosyn is achieved by administering an amount of
approximately 250 mg/head.
The invention further provides a method for controlling an
ectoparasitic infestation, wherein the ectoparasite includes lice, ked and blowfly
strike, in short wool sheep by administering to the sheep, a spinosyn, or an analogue or derivative thereof at a concentration of from 1 to about 25 ppm, such that any wool,
milk or tissue residue from the spinosyn in the sheep is present in an environmentally
acceptable amount immediately or within about a month following administration.
The effect of a concentration of about 25 ppm of spinosyn can be
achieved by administering about 125 mg/head to the sheep.
Other useful spinosyn concentrations for administering to short wool
sheep are about 10, 3, and 1 ppm of spinosyn in the formulation.
In another aspect the invention provides a method for controlling an
ectoparasitic infestation, including lice, ked and blowfly strike, in long wool sheep by
administering to the sheep, a spinosyn, or an analogue or derivative thereof at a
concentration of about 50 ppm or less, such that any wool, milk or tissue residue from
the spinosyn in the sheep is present in an environmentally acceptable amount
immediately or within about a month following administration.
Other useful spinosyn concentrations for administering to long wool
sheep are about 25, 20, or 10 ppm.
Still another aspect of this invention provides a method for controlling
an ectoparasitic infestation, including li e, ked and blowfly strike, in long wool sheep
by administering to the sheep, a formulation wherein the spinosyn, or analogue or
derivative thereof, is present at a concentration of about 50 ppm or less, such that any
wool, milk or tissue residue from the formulation in the sheep is present in an
environmentally acceptable amount immediately or within about a month following
administration of the formulation.
Particularly useful methods for administering the formulations of this
invention in short and long wool sheep are using a dip wash or jetting fluid. Another aspect of this invention provides a method for controlling an
ectoparasitic infestation, including lice, ked and blowfly strike, in long wool sheep by
administering to the sheep in the last 6 months of the growing season, a spinosyn or
an analogue or derivative thereof, at a concentration of about 50 ppm or less , such
that any wool, milk or tissue residue from the spinosyn in the sheep is present in an
environmentally acceptable amount.
For the purposes of the present application, the term 'insecticide' is
defined to include acaracide, ectoparasiticide and miticides. Similarly, for the
purposes of the present application, the term 'insect' is defined to include, but is not
limited to mosquitoes, lice, fleas, flies, ticks and mites. The term 'ectoparasite' is
similarly defined to include, but is not limited to, members of the insect order Diptera,
Phthiraptera, and Acarina, and parasites and other insects which are parasitic during
all of their life cycle or only part of their life cycle, such as only the larval or adult
stage.
The term, 'small ruminant' or 'small ruminant animal' refers to sheep,
goats or camellids (including alpacas, llamas and vacuna, etc.).
The term 'spinosyn or an. logue or derivative thereof is defined to
include an individual spinosyn factor (A83543A-H, J-W or Y) an N-demethyl
derivative of an individual spinosyn factor, or salt thereof, or a combination thereof.
As stated above, the term "A83543 compound" is also used herein to mean an
individual spinosyn factor, or a derivative or salt thereof, or a combination thereof.
The term "controlling an insect infestation" refers to preventing onset
of an infestation of insects in a susceptible animal or to decreasing or eliminating the number of living insects or viable insect eggs on the animal. The extent of reduction
somewhat depends on the application rate of the compound and the compound used.
The term 'effective amount' means the amount which is sufficient to
prevent or cause a measurable reduction in the insect population after treatment .
The term 'short wool sheep' means sheep with 6 weeks or less growth
of wool since the last date of shearing.
The term 'long wool sheep' means sheep with more than 6 weeks
growth of wool since the last date of shearing.
The term 'withholding period' means the period after treatment during
which the wool/meat/milk of animals treated with a insecticide cannot be harvested.
The withholding period of course differs in respect of the chemical nature of the
active in the insecticide.
The term 'environmentally acceptable amount/level' refers to the
amount of residue of an insecticide that is permissible in the wool, tissue and milk of
treated small ruminant animals such as sheep, goats, and camellids. According to the
Australian MRLs (Maximum Residue Levels) for spinosad, published in the
Commonwealth of Australia Gazette (N tional Registration Authority for Agricultural
and Veterinary Chemicals) or "NRA" January 1999 edn, edible offal (mammalian)
has a MRL of 0.05 ppm (= 50 ng residue/g offal). Meat (mammalian in the fat) has an
MRL of 0.2 ppm (=200 ng residue/g meat). In the U.S., the equivalent limits are:
mammalian in the fat: 600 ng residue/g meat; edible offal: 200 ng residue/g offal and
whole muscle: and 40 ng residue/g muscle.
In respect of wool residues, a recent report issued in November 1998
by the NRA and The Woolmark Company entitled 'The residue implications of sheep ectoparasiticides' addresses the 'environmentally acceptable amounts' of residues in
sheep meat and wool in great detail. The current Australian guidelines state that the
residue levels of insecticide on wool must not exceed 13 mg/kg raw wool and the
residue levels in scouring effluent must not exceed 1 mg/L scouring effluent. The
allowable amounts depend on the aquatic toxicity profile of the chemical. For the
UK, synthetic pyrethroids (SPs), must be < 0.06 mg/kg.
From the environmental toxicology the average allowable scouring lot
concentration of spinosad is estimated to be approximately 15 mg/kg or higher.
An advantage of this invention is that the critical environmental
residue limit for harvested wool and the relevant MRL in respect of meat and milk is
met with a zero (0) withholding period in respect of meat/milk/tissue from sheep,
goats and camellids treated with the formulations and methods of the present
invention.
In other words, there is a zero withholding period in respect of
meat/milk from small ruminant animals such as sheep, goats and camellids treated
,vith the formulations and methods of tr ~- present invention, as well as a zero
withholding period in respect of wool harvested from these animals treated with the
formulations and methods of the present invention.
This invention is based on the surprising discovery in sheep that the
spinosyns, i.e. a spinosyn factor or an analogue and derivative thereof, exhibit
insecticidal activity at very low concentrations, much lower than those used or
previously contemplated in sheep. It has been discovered that at even at 1 ppm,
spinosyn compounds have 100% efficacy as insecticides, particularly ectoparasiticides. Spinosyn compounds are usually in the form of either an emulsion
or a suspension, but at such low concentrations they are advantageously in a solution
form. As the spinosyn formulations of the invention are highly effective, they can be
manufactured and supplied as low volume products which are easier to supply, take
up less storage space and are easier to deliver to the farmer. The smaller quantities
needed also means that the formulations can be supplied as dilute ready-to-use
products in smaller packages which are easily disposed of.
Most importantly, these formulations and methods can be applied even
late in the growing season (i.e., in the last 6 months). Due to the low concentrations
at which the formulations are being used, they are practically non-toxic to humans and
animals. Further, residues in the wool and tissue of animals treated with the
formulations are reduced to environmentally acceptable levels. Minimal chemical
residues are found in the milk of such animals treated with the formulations and
methods of the present invention, which is of economic advantage to the farmer as
processing costs are reduced. No skin irritation or dermal toxicity to shearers results
from the methods and formulations of this invention. Environmental contamination is
also minimised, with waste dip wash, w ste jetting fluid and other run off from treated
animals having minimal levels of chemicals and therefore representing only low
environmental contamination.
Another advantage is that the spinosyns are very efficacious at low
levels and have no apparent cross resistance to existing compounds. Thus, the present
invention is of utility against parasite populations on sheep or small ruminants that
have existing levels of resistance to currently used products. As discussed supra, the formulations of the present invention can be
used in controlling pests on small ruminant animals such as sheep, goats and
camellids (including alpacas, llamas and vacuna etc.). Such pests include
ectoparasites such as blowfly strike, lice, ked, mites, itch mite, sheep scab, screw
worm, bot flies, ticks, fleas, and related arthropod pests. The spinosyns can be
formulated into a variety of end use formulations and products which are easy to use.
In summary, food safety, operator safety and minimisation of adverse
environmental effects are advantages resulting from the present invention. Thus, the
present formulations provide advantages over commercially available ectoparasitic
formulations for use in sheep and small ruminants.
Formulations containing the spinosyns are generally administered
topically to the relevant animal. Such topical application can take the form of
dipping, showering, jetting, spraying, manually applying such as dusting, or otherwise
placing or laying the formulation containing the active substance/s on the animal.
Accordingly, usually the spinosyn factor/s and analogues and derivatives thereof are
formulated into a number of topically applied insecticidal formulations.
Topical insecticidal formulations include spot-ons, pour ons, sprays,
dips, dusts, lotions, gels, ointments, salves, dressings, towels, cremes, sticks, soaps,
shampoos, collars, medallions, eartags and tail bands. Pour-on formulations,
including both aqueous and organic-solvent-based ones, as well as emulsions and
suspensions, are preferred. More preferred are dip wash formulations, jetting fluid
formulations and jetting/spray race formulations. The active component-the spinosyn factor/compound- may be present
as a single compound, a mixture of two or more compounds, a mixture including at
least one of A83543A and A83543D, or a mixture of at least one A83543 compound
together with the dried portion of the fermentation medium in which it is produced.
One preferred active component used in the method of the present invention is
spinosad which is a product comprised of 50-85% spinosyn A and 50-15% spinosyn
D.
The active component-the spinosyn factor/compound- may also be
present as a salt in the formulations and methods of this invention. The salts would be
prepared using standard procedures for salt preparation. For example, spinosyn A can
be neutralised with an appropriate acid to form an acid additional salt. The acid
addition salts of spinosyns which can be used in the present invention are useful and
include salts formed by reaction with either an organic or inorganic acid such as, for
example, sulfuric, hydrochloric, phosphoric, acetic, succinic, citric, lactic, maleic,
fumaric, cholic, pamoic, mucic, glutamic, camphoric, glutaric, glycolic, phthalic,
tartaric, formic, lauric, stearic, salicyclic, methanesulfonic, benzenesulfonic, sorbic,
picric, benzoic, cinnamic and other like xids.
The spinosyn factor/s or analogues or derivatives thereof can be mixed
with one or more physiologically acceptable carriers or excipients to formulate the
insecticide formulations of the present invention. The spinosyn factor/s or analogues
or derivatives thereof can also be mixed with other commonly used ectoparasiticidal
compounds in the insecticide formulations used in the present invention.
The formulations of the present invention can take the form of
concentrated formulations which are dispersed in water for application, such as pour on formulations, or dust or granular formulations which are applied without further
treatment.
Preferably, the formulations of the active spinosyn compound are in
the form of aqueous suspensions or emulsions prepared from concentrated
formulations of the compounds. Such water soluble, water-suspendible or
emulsifiable formulations are generally liquids, generally called emulsifiable
concentrates or aqueous suspensions.
It is particularly preferable that the active formulations are in the form
of a suspension concentrate. Emulsifiable concentrates and solution concentrates, as
well as wettable powders, are also preferred.
Generally, emulsifiable concentrates of the A83543 compounds
comprise a convenient concentration of an A83543 compound dissolved in an inert
carrier which is either a water-miscible solvent or a mixture of a water immiscible
organic solvent and emulsifiers. A preferred concentration range is 1-500 g/L of
spinosyn compound. More preferably the concentration range is selected from the
group consisting of 1-400 g/L, 1-350 g/L, 1-300 g/L, 1-250 g/L, 1-200 g/L, 1-150 g/L,
1-100 g/L, 1-90 g/L, 1-80 g/L, 1-70 g/L. 1 -60 g/L, 1-50 g/L, 1-40 g/L, 1-30 g/L, 1-20
g/L, even more preferably 25 g/L. Useful organic solvents include aromatics
including xylenes and petroleum fractions. Other organic solvents may also be used,
such as the terpenic solvents, including rosin derivatives, aliphatic ketones such as
cyclohexanone and complex alcohols such as 2-ethoxyethanol.
Suspension concentrates (SC) comprise suspensions of the active
water-insoluble compound (including one or more spinosyn compounds) dispersed in
an aqueous vehicle at a concentration in the range of from about 1-500 g/L. Preferably, the concentration range is selected from the group consisting of about 1-
400 g/L, about 1-300 g/L, about 1-250 g/L, about 1-200 g/L about 1-150 g/L, about 1-
100 g/L, about 1-50 g/L, about 1-45 g/L, about 1-40 g/L, about 1-30 g/L, more
preferably about 25 g/L. Generally the suspensions are prepared by finely grinding
the spinosyn compound and mixing it into a vehicle comprised of water and
surfactants chosen from such types as nonionic, sulfonated lignins and alkylsulfates
and suspending agents such as xanthan and guar gums. Other inert ingredients may
also be added.
The suspension concentrates and emulsions are preferably diluted with
water to obtain the desired spinosad concentration in the final formulation which is
applied in the methods of the invention. The active A83543 compounds can also be
applied as insecticides to small ruminant animal species in the form of an aerosol
composition. In such compositions, the active spinosyn compound is dissolved in an
inert carrier, which is a propellant mixture.
Preferably, the carriers or excipients used in the /insecticidal
formulations of the invention include dust carriers, solvents, emulsifϊers, wetting and
dispersing agents and water. Selection < "the carrier is of course made on the basis of
compatibility with the desired insecticide, including such considerations as pH,
moisture content and stability.
In one preferred formulation, the insecticide takes the form of an
emulsion comprising a solution of the active spinosyn compound/s in an organic
solvent, with the optional addition of a surfactant. Water emulsion sprays from such
an emulsion formulation are commonly used. Other preferred formulations of the present invention can take the form
of solids, e.g., wettable powders, dusts or granular compositions. These can then be
compacted to form water dispersible granules. Wettable powders can be used as spray
applications. Other possible formulations include granules or pellets where the
carrier, such as an absorbtive clay, is impregnated with the active.
Advantageously, the method of the invention can be applied as an early
season treatment, or as a late season treatment within the last 6 months of the growing
season when the wool is long. The active spinosyn compound or compounds are
generally present in a concentration of about 50 ppm or less upon application to sheep
or other small ruminants. Other useful concentrations of the active spinosyn
compound or compounds for application to sheep and other small ruminants are 35
ppm, 25 ppm, 20 ppm, 10 ppm, 5 ppm, 4 ppm, 3 ppm, 2 ppm, or 1 ppm.
Generally, the rate, timing and manner of effective application will
vary with the identity of the parasite and other factors. In general, ectoparasite control
is obtained with topical application of liquid formulations containing from about 1 to
10 ppm of spinosyn compound or compounds in respect of short wool animals and 10
Lo 50 ppm in respect of long wool anim. !s. Conventional veterinary practices are
used in application of the active compound to the animal. Such practices include
spray, back rubbers, and dip tanks.
A preferred composition for use in the present methods of treatment is
a suspension concentrate containing spinosad at a concentration of 25 g/L. If desired,
a dispersant may be added to improve suspendability.
A preferred formulation contains the following ingredients: Ingredient Percent (w/w) Sample batch (2)
Spinosad 2.76 41.4
Propylene glycol 10 150
Surfactant 2 30
Mineral Thickener 2 30
Xanthan Gum 0.2 3
Antimicrobial Agent 0.2 3
Antifoam Agent 0.1 1.5
Water, deionised 82.74 1241.1
Total 100 1500
In one embodiment of an aqueous suspension, the spinosyn is wet-
milled as a "grind batch," i.e., spinosad, surfactant, water, and antifoam as needed. A
typical "grind batch" contains the following ingredients:
(g)
Spinosad 41.4
Surfactant 30
Water, deionised 100
Antifoam Agent 1
Total 172.9
A preferred nonionic surfactant to incorporate into the aqueous
suspension of spinosad is PLURONIC P-123™.
A "hydrated suspension batch" is also formed by blending a hydrated
suspension of the mineral thickener wi '- xanthan gum hydrated in propylene glycol,
along with an antimicrobial agent A typical hydrated suspension batch contains the
following ingredients:
(g)
Propylene glycol 150 Mineral Thickener 30
Xanthan Gum 3 Antimicrobial Agent 3 Water, deionised 1041.1 Total 1227.1 The hydrated suspension batch and additional water as needed are
blended with the grind batch to prevent syneresis, or separation of clear watery fluid
from suspended milled solids. The appropriate amount of the hydrated suspension
batch to be blended with the grind batch to complete the formulation is determined
based upon the percent recovery of the grind batch after particle size reduction.
A particularly useful mineral thickener is colloidal magnesium
aluminum silicate, such as VEEGUM, that disperses and wells in water. A suitable
xanthan gum in one that is heat stable with a good tolerance for strongly acidic and
basic solutions such as RHODOPOL 23™.
Other formulations can also be used in the present methods of
application of ectoparasiticidal formulations to sheep and small ruminants. For
example, emulsifiable concentrates containing spinosad can be made and used for
dilution and subsequent application to sheep. For example, a 25 g/L spinosad
emulsifiable concentrate can be prepared in an aromatic hydrocadrbon such as
Aromatic 150 containing the following ingredients: spinosad (90% active ingredient,
3.05 weight percent), sulfonate/nonionic surfactant blends (a total of 10 weight
percent and aromatic hydrocarbon (86.9 " weight percent). As an alternative, spinosad
can be formulated as an emulsifiable concentrate in methyl oleate, potentially safer
solvent, than the aromatic hydrocarbon.
The methods of the present invention, particularly the methods of
treating ectoparasites in sheep can be performed in the following manner:
1) To eradicate lice, sheep should be throughly wetted to the skin, 2 to
6 weeks after shearing, with a solution containing 5 to 20 ppm spinosad. A plunge or shower dip charged at about 5 to 20 ppm and reinforced at about 20 ppm is
recommended.
2) To control lice in sheep with long wool (> 6 weeks after shearing),
sheep should be hand jetted with about 25 ppm spinosad; 0.5 L should be used per
month of wool per sheep. Plunge and shower dips and spray races may also be used.
3) To treat fly stike, the wound should be thoroughly wetted with
about 25 ppm spinosad - applied as a wound dressing or using a jetting hand piece.
4) To prevent fly stike for around 4 (to 6) weeks, 25-50 ppm spinosad
should be applied along the back, around the breech, around the pizzle of wethers and
on the heads of rams; 0.5 L should be used per month of wool per sheep.
The methods as described above can also be used to control sucking
lice, sheep ked and mites.
Examples
Example 1 : Spinosad Dip Formulations for the Control of Bovicola Ovis on Sheep
Spinosad can be formulated as a suspension concentrate. Three
formulations of spinsoad were made into two emulsifiable concentrates, one utilising
an aromatic hydrocarbon solvent and one utilising oleate, and an aqueous
suspension/suspension concentrate. Each formulation was prepared at two
concentrations, namely containing 0.2 and 1 g/L spinosad. These were each diluted
1 :5000 in water to give 0.04 and 0.2 ppm dip washes.
Six fine-wool Merino sheep infested with a strain of lice highly
resistant to synthetic pyrethroids were plunge dipped in each dip two weeks after
shearing. Lice counts were conducted on the day of treatment before dipping and
7,14, 28, 42 and 56 days after treatment. The numbers of lice on sheep treated with
water only (i.e. 0 ppm) increased slightly during the study.
The results with regards to lice numbers on sheep treated with the
various formulations of spinosad in this example, are set out below in Table 1.
Subsections (a) - (g) provide the lice counts observed with the control animals and
with each concentration of the three listed spinosad-containing formulations.
Table 1. Lice Counts
a) Control
Figure imgf000026_0001
b) Emulsifiable Concentrate in Aromatic Hydrocarbon at 0.04 ppm
Figure imgf000026_0002
Figure imgf000027_0001
c) Emulsifiable Concentrate in Aromatic Hydrocarbon at 0.2 ppm
Figure imgf000027_0002
d) Emulsifiable Concentrate in Methyl Oleate at 0.04 ppm
Figure imgf000027_0003
Figure imgf000028_0001
e) Emulsifiable Concentrate in Methyl Oleate at 0.2 ppm
Figure imgf000028_0002
f) Aqueous Suspension at 0.04 ppm
Figure imgf000028_0003
g) Aqueous Suspension at 0.2 ppm
Figure imgf000029_0001
Example 2a: Dose determination for the treatment of sheep body lice
(Bovicola ovis)
i) Short wool sheep, application < six (6) weeks after shearing in the form of a dip
Two dose titration studies were conducted in respect of spinosad
applied as a dip for the control of Bovicola ovis on sheep. Spinosad, prepared as an
emulsifiable concentrate, was diluted 1 :1000 in water to obtain formulations of 0, 1.0,
5.0, 20 and 100 ppm concentration and formulations of 0, 0.04, 0.2 and 1.0 ppm
concentration. Fine, short-wool Merino sheep infested with a strain of lice highly
resistant to synthetic pyrethroids were plunge dipped in the dilute solution two (2)
weeks after shearing. During the first titration study, 5 dips were made, with spinosad
being applied at 0, 1.0, 5.0, 20 and 100 ppm to 6 sheep per each concentration by way
of plunge dipping each group of six sheep. During the second titration study,
spinosad was applied at four different concentrations: 0, 0.04, 0.2 and 1.0 ppm, again
each concentration was applied to six (6) sheep by plunge dipping. Lice counts were conducted on the day of treatment before dipping and
7, 14, 28, 42, 56 and 84 days after treatment. The number of lice on sheep treated
with vehicle and water only (0 ppm) declined following dipping although remained at
a satisfactory level for the duration of the trials. In the first titration study, a dose
response was not observed as all spinosad treatments were 100% effective and no live
lice were found after treatment.
In the second titration study, a dose response was observed. An
average of 1.5 lice per sheep was seen 1 week after dipping in 1.0 ppm but on days
14, 28, 42, 59 and 84, 0-0.3 lice/sheep were seen. The 0.2 ppm formulation resulted
in 73-94%o efficacy and the 0.04 ppm dip gave 38 to 60% efficacy, depending on the
day of counting. Based on the second study, the estimated concentration giving 100%
efficacy was 2.0 ppm.
ii) Long wool sheep, application in the form of a jetting spray. 6 to 52 weeks after shearing
Thirty fine-wool Merino ewes with 6 months wool (5 cm long) were
ranked and block allocated according to lice count into 5 groups of 6 sheep. Spinosad
suspension concentrate (25 g/L) was diluted in water to give 0, 2, 5, 15 and 45 ppm
dilutions. 5 L of each diluted concentrate was jetted onto six (6) sheep according to
standard agricultural practice. The numbers of adult and nymphal lice at each of 40
fleece partings on each sheep was determined the day before jetting and 14, 28, 56
and 84 days after jetting. The control sheep (i.e., those treated with 0 ppm) were
jetted with 350 ppm temephos 70 days into the study to relieve rubbing and skin
irritation.
Spinosad applied at all rates provided >95% efficacy against sheep
body lice within 14 days of treatment. At 56 days post treatment, spinosad at the same rate of 45 ppm provided 100% efficacy and the 2.0 ppm rate gave 98.4%
efficacy. The level of efficacy given by 2.0 ppm spinosad 14 days post treatment was
greater than that provided by 350 ppm temephos 14 days post treatment.
Example 2b: Evaluation of spinosad for the treatment of blowfly strike on sheep caused by Lucilia cuprina
i) Fine wool sheep, application in the form of a wound dressing
Fifteen fine wool Merino sheep with approximately 6 months wool
growth were implanted at six (6) sites with approximately 100 first instar of Lucilia
cuprina. Forty eight hours after implantation, the sites were assessed and the viable
sites treated. Emulsifiable concentrates containing 0, 2, 5, 15, 45 and 135 g/L
spinosad were diluted 1 : 1000 in water to give emulsions of 2, 5, 15, 45 and 135 ppm.
Each treatment was applied to 3 sheep (18 sites) in 20, 40 or 60-mL volumes-2
volumes per sheep per concentration. Each site was examined for larval survival and
development 24 hours after treatment.
As concentration increased, the treatments became progressively more
lethal. For quick 100% efficacy, 80 ppm or more was required. Nonetheless, 15 and
20 ppm gave 100% efficacy at 83% of sites after 24 hours. All concentrations,
however, had an adverse effect on larval survival and no strike in any treated site
developed normally. Indeed, the surviving larvae seen in all the treated strikes in the
first study would probably have died in the next 24 hours as was seen in the second
study where all treatments gave 100% mortality at all sites 48 hours after application.
Varying the volume of treatment applied from 20 to 60 mL had no effect on efficacy.
iO Long wool sheep, application in the form of a jetting fluid Ten cross bred Merino/Suffolk wethers with approximately 12 months
wool growth and 2 Merino wethers with 6 months wool growth were implanted at 6
sites with approximately 100 first instar oϊ Lucilia cuprina. Seventy two (72) hours
after implantation, the sites were assessed and the sheep were treated. Suspension
concentrate containing 25 g/L spinosad was diluted 1 : 1000 and 1 :500 in water to give
suspensions of 25 and 50 ppm. A 25 ppm suspension was also prepared with wetting
agent added at the rate of 1 :1000. Each treatment was applied to 4 sheep (24 sites)
using a commercial jetting wand. Each site was examined for larval survival and
development 1, 2.5-3 and 5-6 hours after treatment.
Within one hour of treatment at most sites, there was movement of
larvae away from the site of implantation, up the wool staple. After 2.5 - 3 hours
there were no normal larvae (except 1 site that jetting fluid had not reached) and many
abnormal larvae. By 5-6 hours after treatment, most larvae were dead or missing
from the site of implantation. Increasing concentration from 25 to 50 ppm did not
improve efficacy and neither did adding surfactant.
iii) Prevention, eval. ation of spinosad for the prevention of blowfly strike on sheep caused by Lucilia cuprina
Spinosad emulsifiable concentrates were diluted 1 :1000 in water to
give 0, 2, 5, 15 and 45 ppm emulsions and applied as jetting fluids to the backs of
each of 3 sheep. Fifteen fine wool merino sheep with approximately 6 months wool
growth were used. 3, 8, 15, 22, 29 and 36 days after treatment each sheep was
implanted at two sites on the back with approximately 100 first instar Lucilia cuprina
maggots. Each site was examined for maggot survival and development 24, 48 and 72
hours after implantation. The degree of maggot killing or inhibition of maggot development was related to concentration and time since treatment. 2 ppm gave
100%> mortality of applied maggots at 3 or more of 6 sites for less than 2 weeks.
Increasing the concentration to 5 ppm extended maggot death at 3 of the 6 sites to 4
weeks. The 15 ppm results were variable, but only lasted 4 weeks. 45 ppm gave
complete mortality of maggots at 4 of 6 or 5 of 6 sites for 4 weeks and at 3 of 6 sites
at 5 weeks.
Example 2c: Evaluation of spinosad for the treatment of sheep ked (M. ovinus)
i) Three (3) shorn sheep and 3 unshorn sheep sprayed with 1 L
each of 100 ppm spinosad.
Shorn sheep - 100% keds dead by 1 day after treatment
Unshorn sheep- some live ked seen 1, 3 and 7 days after
treatment. All were dead by 14 days after treatment.
ii) Six (6) recently shorn sheep infested with ked were divided in 3
groups of 2 sheep. The sheep in group 1 were sprayed with 1 L
containing 25 ppm spinosad; those in group 2 with 50 ppm
spinosad, and the group 3 sheep were treated with vehicle only
(controls). Sprays containing 25 and 50 ppm spinosad killed all
keds within 1 day. Counts on control sheep declined after
shearing but much less rapidly than treated sheep.
Example 3a: Dose confirmation and protection period for the treatment of sheep body lice (Bovicola ovis) i) Short wool sheep, application < six (6) weeks after shearing in the form of a dip
Thirty-five lice-free Merino sheep were plunge dipped in an aqueous
suspension containing 5 ppm spinosad. 35 similar lice-free sheep were used as
controls. 1, 2, 3, 4 and 6 weeks after treatment, five (5) treated and 5 untreated
(control) sheep were implanted with 50 viable lice on the shoulder and hip. The
implantation sites were examined 4 weeks later and again another 4 weeks later if no
live lice were found at the first examination.
Lice placed on treated sheep 1 week after treatment failed to survive.
The lice placed on the untreated sheep survived. Lice implanted 2 weeks after
treatment survived in low numbers on 2 of 5 treated sheep and on all of the 5 control
sheep. Numbers of surviving lice increased with time between dipping and times of
subsequent examination. By five (5) weeks after treatment, lice numbers on treated
sheep were approaching those seen on untreated control sheep.
Example 4: Decay profile of spinosad in sheep wool following dipping
Spinosad suspension at 5 g/L and 20 g/L was diluted 1:1000 with
water. The concentration of the two dip washes were therefore 5 ppm and 20 ppm,
respectively. Nine Merino ewes with 2 weeks wool and having had no ectoparasite
treatment for 12 months were used and divided into 3 groups of 3 sheep. Each group
was housed in an outdoor pen, which was raised with a mesh floor. Each pen had a
roof over 1/3 of the pen and had metal walls between each pen.
Two sheep dip washes were prepared in a calibrated stainless steel
bath. 475 mL of dam water was added to the bath, 475 mL of test article was then
added to the bath and mixed thoroughly and a 40-mL sample of the dip was collected. 6 of the sheep were individually dipped for 30 seconds with the head submerged twice
in the 5 ppm dip wash, while 3 sheep were similarly individually treated in the 20
ppm dip wash.
Following dipping, circumferential wool samples were collected using
electric hair clippers with a cutting width of 4.5 cm from all sheep 3 days prior to
treatment and on a range of days post treatment. Three of the sheep treated with 5
ppm spinosad were sampled on days 1, 2, 4, 7, 9, 11, 14, 17 and 21 post treatment,
while the remaining three sheep were sampled on days 7, 14, 21, 28, 35, 42, 49, 56
and 64. The three sheep treated with 20 ppm spinosad were sampled on days 7,14,
21, 28, 42, 56, 70, 86 and 98. The wool samples were then analysed by
immunoassay.
Following dipping in 5 ppm spinosad, there was a maximum residue of
3.3 ppm which declined with a half life of about 2 weeks. After 64 days, the residue
was 0.27 ppm which was 8% of the initial residue. Following dipping in 20 ppm, a
residue of 16.4 ppm was seen, which took 5 weeks to decline to 8 ppm, but after that
the half life was about 2 weeks. After 98 days, the residue was 1.36 ppm, which was
?>% of the initial residue.
Example 5: Spinosad residues in sheep meat, fat and offal four days following dipping in 50 ppm spinosad dip formulation
Two previously sheared sheep were dipped in an aqueous suspension dip formulation containing 50 ppm spinosad for 30 seconds, with the head being dunked twice, and then placed in a floor pen for four days. The sheep were sacrificed and necropsied at the end of those four days; and samples of kidney, liver, muscle, perirenal and abdominal fat were collected. The tissues were transferred to a -20°C freezer until processing. The tissue samples were chopped, frozen with dry ice and then ground using a hammermill. The samples were then placed in a -20°C freezer until assay. Samples were assayed using Elanco Method B05873 (EPA Method MRID 44058822, Dow Agro Science Method GRM 95.03) "Determination of spinosad and metabolites in Beef tissues, milk and cream by HPLC with UV detection" which is certified for use with sheep tissues. The samples were assayed in duplicate with the results shown below in Table 2. The residue definition of spinosad is the sum of spinosyn A and spinosyn D. However, all residues are spinosyn A, as residues of spinosyn D, N-demethyl spinosyn D and spinosyn B were less than the limit of quantitation of the certified method.
Table 2: Total Spinosad Residue (ng/g) - Day 4 after 50 ppm dipping
Animal A Animal B Average
Abdominal fat 150.0 177.5 163.8 Perirenal fat 99.9 142.7 121.3 Liver 34.2 38.9 36.6 Kidney 23.3 28.3 25.8 Muscle 14.9 13.5 14.2
Example 6: Measurement of the residue decay profile of spinosad in sheep wool following dipping in 10 ppm spinosad and jetting with 25 ppm spinosad.
Table 3. Mean concentration (mg/kg) and total mass (μg) of spinosad on wool band samples collected after sheep were dipped in 10 ppm spinosad suspension in water at days 1 through to 170 after treatment.
Figure imgf000036_0001
Merino sheep with 6 weeks wool growth were dipped in an aqueous suspension containing 10 ppm spinosad. Circumferential strips of wool were collected from each sheep after treatment to allow the estimation of spinosad residues and residue decay profiles. Wool residues decayed with an average degradation rate (half- life) of 26 days. Table 4. Mean concentration (mg/kg) and total mass (μg) of spinosad on wool band samples collected after sheep were jetted with an aqueous suspension containing 25 ppm spinosad at days 1 through to 84 after treatment.
Figure imgf000037_0001
Spinosad decayed with a half-life of 30 days in sheep with 9 months wool growth jetted with 25 ppm spinosad.
On the basis of the toxicity of spinosad to aquatic organisms, a provisional environmental assessment of discharges from wool scouring has established target concentrations for wool processing lots in Australia and in Europe of 66 mg/kg and 15 mg/kg respectively. (I M Russell, N T Campbell, J T Rothwell, Proc Aust Sheep Vet Soc 2000, pp 108-115, ANA Conf Perth 2000). The wool residues seen immediately following treatment are well below the projected maximum permissible residues for scouring lots in Europe which has the most stringent Environmental Quality Standards. Even following late season jetting treatment for blowfly prevention, sheep will be left at least a month before shearing and following other treatments for up to 12 months after treatment allowing wool residues to decay. In addition the wool in a processing lot is made up of wools treated in early season, wools treated in late season, untreated wools, and wools treated with other chemicals. This blending will allow the spinosad residue from any farm to be diluted by these other wools. Therefore treatment of sheep with spinosad at the recommended rates will not cause wool residues to breach any wool scour environmental parameters and will not require the establishment of a wool with-holding period following treatment.
Spinosad has a high margin of safety for farm workers due to the short half-life of spinosad in wool grease, the very low level of dermal absorption and low mammalian toxicity of the active ingredient. Sheep treated with spinosad present no risk to shearers, wool handlers or other farm workers.
Example 7: Tissue residues following dipping in 10 ppm spinosad and jetting with 25 ppm spinosad. Thirty seven fine wool Merino ewes and wethers with 6 weeks wool
growth were dipped in 10 ppm spinosad suspension in water. Thirty seven Merinos
with 9 months wool growth were jetted with 25 ppm spinosad. Animals were
slaughtered 5, 12, 15, 21, 39and 56 days after treatment and samples of back fat,
muscle, liver, peri-renal fat and kidney collected and assayed for spinosad residue.
The limit of quantification (LOQ) was 0.01 mg/kg and the limit of detection (LOD)
was 0.003 mg/kg. Residues of spinosad greater than the limit of quantification were
found in fat samples from animals treated via a plunge dip and traces (values between
the LOQ and LOD) were found in fat from jetted animals. Traces of spinosad were
found in the liver and kidney tissues of animals that were plunge dipped, but except
for one liver sample collected 12 days after treatment, not from jetted animals. Offal
residues were below the LOD 15 days after treatment. Residues of spinosad in the
main edible tissue of sheep, meat were undetectable at all times.
The highest residues recorded were in tissues collected 5 days after
dipping and were 3 to 5 times lower than the lowest relevant residue limit set.
Therefore dipping sheep in 10 ppm spinosad or jetting them with 25 ppm spinosad
does not infringe established minimuni residue limits (MRL) or tolerances and no
with-holding period is required. In countries were a MRL is not established and a nil
residue is required a withholding period of 56 days would ensure that the tissue with
the highest residue - fat - would be below the LOD. Likewise offal would be below
the LOD 15 days after treatment and meat residues would be below the LOD at all
times after treatment.
Tables 5. Mean spinosad residues (mg/kg) in fat after dipping in 10 ppm spinosad.
Figure imgf000039_0001

Claims

CLAIMS:
1. An insecticidal formulation for controlling an insect infestation
in a small ruminant animal, said formulation comprising an effective amount of a
spinosyn, or an analogue or derivative thereof, together with an acceptable carrier or
diluent.
2. A formulation of Claim 1 wherein the spinosyn is a component
of spinosad.
3. A formulation of Claim 1 or 2 wherein the amount of spinosyn
in the formulation is selected from the group consisting of 1-500, 1-400, 1-350 , 1-
300, 1-250, 1-200, 1-150, 1-100, 1-90, 1-80, 1-70, 1-60, 1-50, 1-40, 1-30, , 1-25 or 1-
20 g of spinosyn per L of the formulation.
4. A formulation of Claim 1, 2 or 3 wherein the ruminant animal
is a sheep, a goat or a camellid.
5. A formulation of Claim 1, 2, 3 or 4 wherein the amount of
spinosyn present in the formulation is such that the spinosyn residue in any wool,
milk or tissue obtained from the animal immediately, or within about a month,
following application of the formulation is at an environmentally acceptable level.
6. A formulation of Claim 1, 2, 3, 4, or 5 which additionally
comprises another insecticidal agent.
7. An article of manufacture, comprising packaging material and a
formulation for controlling an insect infestation in a small ruminant animal contained
within said packaging material, wherein said formulation comprises a topical unit dose of a formulation of Claim 1, 2, 3, 4, 5 or 6; and wherein
said packaging material comprises a label or package insert with instructions for
topically administering the dose to the animal.
8. The use of a formulation of Claim 1, 2, 3, 4, 5 or 6 in the
preparation of a medicament for controlling an insect infestation in a small ruminant
animal.
9. A use of a formulation of any one of Claims 1 to 6 for
controlling an ectoparasite infestation in a small ruminant animal selected from a
sheep, goat, or camellid, comprising topically administering the formulation to the
animal.
10. A method of controlling an ectoparasite infestation in a small
ruminant animal selected from a sheep, goat, or camellid, comprising topically
administering a formulation of any one of Claims 1 to 6 to the animal.
11. A method of Claim 10 wherein the animal is a sheep, and the
sheep is a short wool sheep.
12. A method of Claim 11 wherein the effective amount of the
spinosyn in the formulation is 10 ppm or less.
13. A method of Claim 12 wherein the formulation is administered
in a dip wash or jetting fluid.
14. A method of Claim 13 wherein the effective amount of the
spinosyn in the formulation is 5 ppm or less.
15. A method of Claim 14 wherein the amount is 3 ppm or less.
16. A method of Claim 15 wherein the amount is about 1 ppm.
17. A method of Claim 10 wherein the animal is a sheep, and the
sheep is a long wool sheep.
18. A method of Claim 17 wherein the effective amount of the
spinosyn in the formulation is 50 ppm or less.
19. A method of Claim 18 wherein the formulation is administered
in a dip wash or jetting fluid.
20. A method of Claim 19 wherein the effective amount of the
spinosyn in the formulation is 25 ppm or less.
21. A method of Claim 20 wherein the amount is 20 ppm or less.
22. A method of Claim 21 wherein the amount is 10 ppm or less.
23. A method of Claim 17 wherein the formulation is administered
within the last six months of the season.
24. A method of Claim 10 wherein the ruminant is a goat.
25. A method of Claim 10 wherein the ruminant is a camellid.
26. An insecticidal formulation for controlling an insect infestation
in a small ruminant animal, said formulation comprising a spinosyn, or an analogue or
derivative thereof, together with an acceptable carrier or diluent, substantially as
hereinbefore described with reference to any one of the Examples.
PCT/US2000/017869 1999-08-12 2000-07-31 Control of ectoparasites using spinosyns WO2001011961A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU66053/00A AU6605300A (en) 1999-08-12 2000-07-31 Control of ectoparasites using spinosyns

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14852499P 1999-08-12 1999-08-12
US60/148,524 1999-08-12

Publications (1)

Publication Number Publication Date
WO2001011961A1 true WO2001011961A1 (en) 2001-02-22

Family

ID=22526135

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/017869 WO2001011961A1 (en) 1999-08-12 2000-07-31 Control of ectoparasites using spinosyns

Country Status (3)

Country Link
AU (1) AU6605300A (en)
CO (1) CO5221104A1 (en)
WO (1) WO2001011961A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664237B1 (en) 1999-08-12 2003-12-16 Eli Lilly And Company Oral treatment of companion animals with ectoparasiticidal spinosyns
US6927210B1 (en) 1999-08-12 2005-08-09 Eli Lilly And Company Ectoparasiticidal aqueous suspension formulations of spinosyns
US6933318B1 (en) 1999-08-12 2005-08-23 Eli Lilly And Company Topical organic ectoparasiticidal formulations
US6955818B1 (en) 1999-12-02 2005-10-18 Eli Lilly And Company Pour-on formulations
WO2005112950A1 (en) * 2004-04-29 2005-12-01 Eli Lilly And Company Spinosyns for wound healing
KR100855417B1 (en) * 2006-10-27 2008-08-29 일라이 릴리 앤드 캄파니 A Pharmaceutical Composition for Wound Healing Comprising Spinosyns
SG159395A1 (en) * 2004-04-29 2010-03-30 Lilly Co Eli Use of spinosyns for wound healing
US7772194B2 (en) 2001-09-17 2010-08-10 Eli Lilly And Company Pesticidal formulations

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0375316A1 (en) * 1988-12-19 1990-06-27 DowElanco Macrolide compounds
WO1998023158A1 (en) * 1996-11-26 1998-06-04 Zeneca Limited Insecticidal compositions and methods
US5767253A (en) * 1992-11-06 1998-06-16 Dow Agrosciences Llc A83543 Compounds; factors Q, R, S, and T

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0375316A1 (en) * 1988-12-19 1990-06-27 DowElanco Macrolide compounds
US5767253A (en) * 1992-11-06 1998-06-16 Dow Agrosciences Llc A83543 Compounds; factors Q, R, S, and T
WO1998023158A1 (en) * 1996-11-26 1998-06-04 Zeneca Limited Insecticidal compositions and methods

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ABSTR.PAP.AM.CHEM.SOC. (217 TH NATIONAL MEETING OF THE AMERICAN CHEMICAL SOCIETY; MARCH 21-25, 1999) *
DATABASE BIOSIS BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; *
DATABASE CROPU [online] D.H.DA ET AL.: "Dermal absorption and metabolism of spinosad in lactating goats", XP002153532, retrieved from EPOQUE accession no. PREV199900165412 *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664237B1 (en) 1999-08-12 2003-12-16 Eli Lilly And Company Oral treatment of companion animals with ectoparasiticidal spinosyns
US6927210B1 (en) 1999-08-12 2005-08-09 Eli Lilly And Company Ectoparasiticidal aqueous suspension formulations of spinosyns
US6933318B1 (en) 1999-08-12 2005-08-23 Eli Lilly And Company Topical organic ectoparasiticidal formulations
US6955818B1 (en) 1999-12-02 2005-10-18 Eli Lilly And Company Pour-on formulations
US8048861B2 (en) 2001-09-17 2011-11-01 Eli Lilly And Company Pesticidal formulations
US7772194B2 (en) 2001-09-17 2010-08-10 Eli Lilly And Company Pesticidal formulations
EA010975B1 (en) * 2004-04-29 2008-12-30 Эли Лилли Энд Компани Use of spinosyns for wound healing
SG159395A1 (en) * 2004-04-29 2010-03-30 Lilly Co Eli Use of spinosyns for wound healing
US7709447B2 (en) 2004-04-29 2010-05-04 Eli Lilly And Company Use of spinosyns for wound healing
AU2004319804B2 (en) * 2004-04-29 2010-08-05 Elanco Us Inc. Use Of Spinosyns For Wound Healing
WO2005112950A1 (en) * 2004-04-29 2005-12-01 Eli Lilly And Company Spinosyns for wound healing
US8536142B2 (en) 2004-04-29 2013-09-17 Eli Lilly And Company Spinosyns for wound healing
KR100855417B1 (en) * 2006-10-27 2008-08-29 일라이 릴리 앤드 캄파니 A Pharmaceutical Composition for Wound Healing Comprising Spinosyns

Also Published As

Publication number Publication date
AU6605300A (en) 2001-03-13
CO5221104A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
US8048861B2 (en) Pesticidal formulations
AU2001291478A1 (en) Pesticidal formulations
JP2003520779A (en) Topical organic ectoparasiticide formulation
WO2001011961A1 (en) Control of ectoparasites using spinosyns
US20030161854A1 (en) Synergistic formulations
EP0915654B1 (en) Process and composition for the antiparasitic treatment of the surroundings of animals
WO2001011962A1 (en) Topical treatment for insect pests in companion animals
AU2010260102B2 (en) Ectoparasiticidal methods and formulations
AU2001239017B2 (en) Synergistic formulations
AU2005202712B2 (en) Synergistic formulations
AU2001239017A1 (en) Synergistic formulations
AU2013224751B2 (en) Ectoparasiticidal methods and formulations
NZ550023A (en) Synergistic pesticidal formulations for the control of dipteran pests
ZA200402103B (en) Pesticidal formulations.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP